Mark Belletrutti MD's Avatar

Mark Belletrutti MD

@mbelletr.bsky.social

#medsky #HemeSky #haemostasis #thrombosis #pediatrics Pediatric Hematologist in Vancouver 🇨🇦 All opinions are my own. Any medical advice should be discussed with your own doctor.

11 Followers  |  35 Following  |  1 Posts  |  Joined: 15.03.2025  |  1.6011

Latest posts by mbelletr.bsky.social on Bluesky

An excellent opportunity for sure as long as funding increases to do this. #science #Medsky

21.03.2025 19:10 — 👍 1    🔁 2    💬 0    📌 0
Post image

Learn more about the history of #women and #hemophilia: A narrative review of evolving beliefs and testing practices.

Read more here: www.jthjournal.org/article/S153...

19.03.2025 15:39 — 👍 4    🔁 4    💬 0    📌 0
The detrimental impact of ferritin “normal” ranges on diagnosis of bleeding disorders in women In this editorial, we use the term “women” to highlight the experiences of and care gaps for women with nonanemic iron deficiency (NAID) and iron deficiency anemia (IDA) and the term “females” in refe...

RPTH Cares about Women's Health 🌸: NAID and IDA are extremely prevalent among women, largely due to iron losses from vaginal blood loss.
Explore the findings: www.rpthjournal.org/article/S247...
@isth.org
#IronDeficiency #WomensHealth

17.03.2025 19:00 — 👍 4    🔁 5    💬 0    📌 0
Preview
Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trial Join author Cedric Hermans on World Hemophilia Day as he discusses his recent RPTH article, "Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trial" with m...

It's time to rethink hemophilia A treatment! Join us on April 17 for a special #WorldHemophiliaDay @rpth.bsky.social Research Recap as we explore findings from the HAVEN 6 trial & discuss why treatment guidelines must evolve to reflect clinical needs: streamyard.com/watch/cY5iiQ...

19.03.2025 14:52 — 👍 6    🔁 6    💬 0    📌 0

@mbelletr is following 20 prominent accounts